ANXA11 and amyotrophic lateral sclerosis: To identify the specific cognitive tests and domains impaired in ANXA11-ALS, we initially compared ANXA11-ALS patients with healthy controls (HC) in a 1:2 ratio, balanced using propensity scores as described in the Methods section.